Search

Search Constraints

You searched for: Author/Creator Thumar, Bhagvanji

Search Results

1. An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Issue 1 (14th March 2012)

3. Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children. (23rd November 2019)

4. Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children. (2nd March 2018)

5. Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated. (6th May 2019)